Science ❯ Biotechnology

Therapeutics

Cancer Treatment Monoclonal Antibodies Gene Therapy AI in Drug Development Antibody Design Protein Engineering Autoimmune Diseases Clinical Trials Antibody Therapeutics Advanced Therapies

Boxer Capital Buys 1.24 Million Vir Biotechnology Shares

The buy underscores improving sentiment, with promising trial data plus a pending Astellas payment bolstering the case.

Cyclerion to Merge With Korsana in Reverse Takeover Backed by $380 Million

Lilly, Samsung Biologics to Open First Gateway Labs Outside U.S. and China in Songdo by July 2027

Vertex’s IgA Nephropathy Drug Hits Phase 3 Goals, FDA Filing Slated for March

Bristol Myers, Janux Strike Exclusive Deal on Tumor-Activated T-Cell Engager

FDA Setback Puts uniQure’s Huntington’s Gene Therapy Filing in Doubt

Takeda and Nabla Bio Expand AI Protein-Design Deal With Potential Payouts Above $1 Billion

Kyoto Researchers Report Crunch Protein That Redirects Phagocytes to Clear Targeted Cells

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion

Frazier Life Sciences Closes $1.3 Billion Early-Stage Biotech Fund

Breakthrough Drug Delivery System Crosses Blood-Brain Barrier